News Center

Home page

Peak Report

News reports

The pharmaceutical industry held a business analysis meeting in the first half of the year.

Release time:

2020-08-14

Pharmaceutical held a first-half business analysis meeting

called for invigorating spirit, pioneering and innovating, and striving to complete the annual target task

News from our newspaper 7# October 10 , Pharmaceutical Company held a first-half business analysis meeting in Jinxi Pharmaceutical Factory to summarize the work in the first half and arrange the work plan for the second half.

Various departments and subordinate enterprises of Pharmaceutical Company reported their work in the first half of the year and put forward their work plans and objectives for the second half of the year. Chief Financial Officer Gong Xiliang analyzed the operation of Pharmaceutical Company in the first half of the year. General Manager Huang Jinlong summarized the work of the pharmaceutical company in the first half of the year, analyzed the existing problems and difficulties, and made arrangements for the work in the second half of the year.

In the first half of this year, the new medical reform and industry supervision have been strengthened day by day. All employees of the pharmaceutical company have worked hard and achieved a series of new results: the national first-class anti-tumor drug deoxypodophyllotoxin for injection has obtained clinical approval and is expected to be included in the national "13th Five-Year Plan" major new drug creation science and technology major project; Desvenlafaxine Succinate Sustained Release Tablets were included in Jinhua Key Science and Technology Innovation Project; jianfeng Pharmaceutical was named 2016 National Intellectual Property Advantage Enterprise by the State Intellectual Property Office. Signed the "Agreement on Capital Increase and Share Transfer of Beijing Huibaoyuan Biotechnology Co., Ltd." and completed the first phase of investment. Bidding and negotiation have achieved phased results. Peak natural products continue to maintain a good momentum of development; Major pharmacies have strengthened in-depth cooperation with hospitals and achieved results; the "three downsides and three improvements" have continued to play an important role in tapping internal potential.

Facing the severe external environment and internal operating pressure, the pharmaceutical company will mainly do the following work in the second half of the year: strengthen marketing management and broaden new space for marketing work; Speed up the pace of new drug development, improve efficiency, and improve quality; Standardize management and improve the level of operation and management, from quality management, internal control management, receivables and inventory management, human resource management, three reductions and three improvements, etc, systematically improve the level of internal management; speed up the pace of information construction, promote the process of internationalization, pay close attention to technological transformation projects, and enhance the stamina of enterprise development. At the

meeting, Huang Jinlong asked all employees to cheer up, change pressure into motivation, find ways to promote all kinds of work in a planned, targeted, measured and responsible way, and work hard to achieve the annual goal of the pharmaceutical company. (This correspondent)

More information

2022 China's Top 100 Building Materials Enterprises 2022 China's Top 100 Cement Clinker Production Capacity Peak even on two authoritative lists

In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)

2023

03-21

Company sends off retired employees

On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.

2023

03-04

On the first day of the new year, group leaders went to the grassroots level.

On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.

2023

02-17

Group Companies Commend 2022 Advanced

On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.

2023

01-29

Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce

On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.

2023

01-12

Peak Pharmaceutical Donates Epidemic Prevention Materials

Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.

2023

01-12

< 1 2 3 4...61 > 跳转到页